The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae

Journal of Clinical Investigation

Volumn 103, Issue 5, 1999, Pages 747-753

  Hu, He ^a   Pierce, Grant N ^a   Zhong, Guangming ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ANIMAL MODEL; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; INFECTION CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 0033105576     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI4582     Document Type: Article

References (31)

1. Dahlen, G.H., and Stenlund, H. 1997. Lp(a) lipoprotein is a major risk factor for cardiovascular disease: pathogenic mechanisms and clinical significance. Clin. Genet. 52:272-280.
2. Mlot, C. 1996. Chlamydia linked to atherosclerosis. Science. 272:1422.
3. Saikku, P. 1997. Chlamydia pneumoniae and atherosclerosis - an update. Scand. J Infect. Dis. Suppl. 104:53-56.
4. Grayston, J.T., et al. 1995. Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery. Circulation. 92:3397-3400.
5. Saikku, P., et al. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet. 2:983-986.
6. Puolakkainen, M., et al. 1993. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J. Clin. Microbiol. 31:2212-2214.
7. Ong, G., Thomas, B.J., Mansfield, A.O., Davidson, B.R., and Taylor-Robinson, D. 1996. Detection and widespread distribution cf Chlamydia pneumoniae in the vascular system and its possible implications. J. Clin. Pathol. 49:102-106.
8. Kuo, C.C. 1995. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15 to 34 years old). Proc. Natl. Acad. Sci. USA. 92:6911 -6914.
9. Ramirez, J.A. 1996. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group. Ann. Intern. Med. 125:979-982.
10. Kalayoglu, M.V., and Byrne, G.I. 1998. Induction of macrophage foam cell formation by Chlamydia pneumoniae. J. Infect. Dis. 177:725-729.
11. Grayston, J.T., et al. 1990. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J. Infect. Dis. 161:618-625.
12. Grayston, J.T., Diwan, V.K., Cooney, M., and Wang, S.P. 1989. Community-and hospital-acquired pneumonia associated with Chlamydia TWAR infection demonstrated serologically. Arch. Intern. Med. 149:169-173.
13. Muhlestein, J.B., et al. 1998. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Circulation. 97:633-636.
14. Fong, I.W., et al. 1997. Rabbit model for Chlamydia pneumoniae infection. J. Clin. Microbiol 35:48-52.
15. Ishibashi, S., et al. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
16. Breslow, J.L. 1996. Mouse models of atherosclerosis. Science. 272:685-688.
17. Bird, D.A., et al., 1998. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice. J. Lipid Res. 39:1079-1090.
18. Palinski, W., Tangirala, R.K., Miller, E., Young, S.G., and Witztum, J.L. 1995. Increased autoantibody titers against epitopes of oxidized LDL in LDL receptor-deficient mice with increased atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15:1569-1576.
19. Tangirala, R.K., Rubin, E.M., and Palinski, W. 1995. Quantitation of atherosclerosis in marine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36:2320-2328.
20. Moazed, T.C., Kuo, C., Grayston, J.T., and Campbell, L.A. 1997. Murine models of Chlamydia pneumoniae infection and atherosclerosis. J. Infect. Dis. 175:883-890.
21. Yang, Z.P., Kuo, C.C., and Grayston, J.T. 1995. Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice. J. Infect. Dis. 171:736-738.
22. Moazed, T.C., Kuo, C.C., Grayston, J.T., and Campbell, L.A. 1998. Evidence of systemic dissemination of Chlamydia pneumomae via macrophages in the mouse. J. Infect. Dis. 177:1322-1325.
23. Nigg, C., and Eaton, M.D. 1944. Isolation from normal mice of a pneumotropic virus which forms elementary bodies. J. Exp. Med. 79:497-510.
24. Grayston, J.T., Kuo, C.C., Wang, S.P., and Altman, J. 1986. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N. Engl. J. Med 315:161-168.
25. Zhong, G.M., Toth, I., Reid, R., and Brunham, R.C. 1993. Immunogenicity evaluation of a lipidic ammo acid-based synthetic peptide vaccine for Chlamydia trachomatis. J. Immunol. 151:3728-3736.
26. Zhong, G.M., et al. 1989. Role of endogenous gamma interferon in host defense against Chlamydia trachomatis infections. Infect. Immun. 57:152-157.
27. Cotter, T.W., et al. 1995. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect. Immun. 63:4704-4714.
28. Su, H., and Caldwell, H.D. 1995. Kinetics of chlamydial antigen processing and presentation to T cells by paraformaldehyde-fixed murine bone marrow-derived macrophages. Infect. Immun. 63:946-953.
29. Zhong, G.M., and Brunham, R.C. 1991. Antigenic determinants of the chlamydial major outer membrane protein resolved at a single amino acid level. Infect. Immun. 59:1141-1147.
30. Capron, L. 1996. Chlamydia in coronary plaques - hidden culprit or harmless hobo? Nat. Med. 2:856-857.
31. Juvonen, J., et al. 1996. Immunohistochemical detection of Chiamydia pneumoniae in abdominal aortic aneurysms. Ann. NY Acad. Sci. 800:236-238.